Orgametril (Lynestrenol)

Lynestrenol, the active ingredient in Orgametril, is a progestogen presented as a tablet for oral use. It is employed to prevent pregnancy in women of reproductive age.

GNH USA supplies Orgametril as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orgametril contains Lynestrenol, a synthetic progestogen that acts within the hormonal contraceptive pathway. - Contraception: prevents pregnancy by suppressing ovulation and inducing endometrial changes that inhibit implantation.

Lynestrenol may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: discomfort or swelling of the breasts. - Weight gain: modest increase in body weight. - Mood changes: irritability or emotional lability. - Irregular bleeding: spotting or breakthrough bleeding.

Serious or Rare Side Effects: - Thromboembolic events: deep‑vein thrombosis or pulmonary embolism. - Severe allergic reaction: rash, itching, swelling, or anaphylaxis. - Liver dysfunction: jaundice, elevated liver enzymes. - Depression: persistent low mood or suicidal thoughts. - Visual disturbances: blurred vision or eye pain. - Cardiovascular hypertension: sudden rise in blood pressure.

Before initiating therapy with Orgametril, several safety considerations are recommended. - Thromboembolism risk: assess personal or family history of clotting disorders. - Liver function: evaluate hepatic health, especially in patients with known liver disease. - Blood pressure: monitor for hypertension, particularly in smokers. - Smoking status: advise cessation, as smoking increases cardiovascular risk. - Medication review: check for concomitant drugs that may reduce efficacy. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Lynestrenol can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Rifampicin and other strong enzyme inducers: may markedly reduce contraceptive efficacy. - Anticonvulsants (e.g., carbamazepine, phenytoin): can lower plasma levels of Lynestrenol. - Protease inhibitors (e.g., ritonavir): may decrease hormonal activity. - St. John’s wort: herbal inducer that diminishes contraceptive effect. - Certain antiretrovirals: may compromise hormonal control.

Moderate Interactions (Monitor Closely): - Azole antifungals (ketoconazole, itraconazole): can increase Lynestrenol concentrations. - Macrolide antibiotics (erythromycin, clarithromycin): may modestly raise hormone levels. - SSRIs (fluoxetine, sertraline): potential for altered menstrual bleeding patterns. - Antihypertensives (beta‑blockers): monitor blood pressure changes. - Herbal supplements (ginseng): observe for any reduction in contraceptive reliability.